Armephaco JSC

Armephaco JSC P/TBV

The Price to Tangible Book Value (P/TBV) of Armephaco JSC (AMP.VN) as of Nov 3, 2026 is 0.92. In the previous year, Price to Tangible Book Value (P/TBV) was 0.94 — a change of -2.01% (lower).

P/TBV

0.92

YoY

-2.01%

Last updated:

Price to Tangible Book Value (P/TBV) of Armephaco JSC is 2025 0.92 . Price to Tangible Book Value (P/TBV) of Armephaco JSC was 2024 0.94 . It decreases by -2.01% lower compared to the previous year.

The Armephaco JSC P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2018
1.06 VND
Jan 1, 2019
1.02 VND
Jan 1, 2020
0.99 VND
Jan 1, 2021
0.96 VND
Jan 1, 2022
0.98 VND
Jan 1, 2023
1.11 VND
Jan 1, 2024
0.94 VND
Jan 1, 2025
0.92 VND
The Armephaco JSC P/TBV history
YEARP/TBVYoY
0.92-2.01%
0.94-15.44%
1.11+13.32%
0.98+1.74%
0.96-2.21%
0.99-3.43%
1.02-3.75%
1.06-3.47%
1.10-3.56%
1.14-4.34%
1.19—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC manufactures pharmaceutical and medical equipment products, focusing on glucose meters, sphygmomanometers, beds, medical exam tables, stools, and syringe destroyers. The company distributes medical devices and equipment through its manufacturing and distribution channels, targeting healthcare providers and hospitals. It also produces and trades diversified medicines, including antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal, and anti-allergic drugs, serving the broader healthcare market. The firm generates revenue from the sale of medical devices and equipment, as well as from pharmaceutical products. Healthcare providers and hospitals purchase the medical devices and equipment, while the diversified medicines are sold to pharmacies and healthcare institutions. Armephaco JSC's product portfolio includes glucose meters, sphygmomanometers, beds, medical exam tables, stools, syringe destroyers, antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal, and anti-allergic drugs. Armephaco JSC's business model centers on the production and distribution of medical devices and pharmaceuticals. The company's primary customers are healthcare providers, hospitals, pharmacies, and healthcare institutions. The revenue streams are derived from the direct sale of medical equipment and pharmaceutical products to these segments, with no mention of additional services or partnerships. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

Price to Tangible Book Value (P/TBV) of Armephaco JSC is 0.92 in 2025.

Price to Tangible Book Value (P/TBV) of Armephaco JSC changed from 0.94 to 0.92, representing a -2.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s Armephaco JSC with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Armephaco JSC

All Key Metrics — Armephaco JSC